{
  "paper_metadata": {
    "pmid": "32398771",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.631+2T>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of splice site variants that may produce alternative transcripts.",
      "key_quotes": [
        "Expression of these transcripts did attenuate the impact of predicted LoF variants such as the canonical splice site variants c.631+2T>G."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.517-2A>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of splice site variants that may produce alternative transcripts.",
      "key_quotes": [
        "Expression of these transcripts did attenuate the impact of predicted LoF variants such as the canonical splice site variants c.517-2A>G."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6842-2A>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of splice site variants that may produce alternative transcripts.",
      "key_quotes": [
        "Expression of these transcripts did attenuate the impact of predicted LoF variants such as the canonical splice site variants c.6842-2A>G."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6937+1G>A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of splice site variants that may produce alternative transcripts.",
      "key_quotes": [
        "Expression of these transcripts did attenuate the impact of predicted LoF variants such as the canonical splice site variants c.6937+1G>A."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.491T>A",
      "protein_notation": "p.Leu164Ter",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of nonsense variants that may produce alternative transcripts.",
      "key_quotes": [
        "In line with the previously demonstrated functionality of variant DelEx12 (51% HDR), variant c.491T>A revealed a moderate functional impact."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.581G>A",
      "protein_notation": "p.Gly194Ser",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of nonsense variants that may produce alternative transcripts.",
      "key_quotes": [
        "As shown for the DelEx4\u20137 variant this alternative transcript encodes a HDR-competent protein isoform."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6901G>T",
      "protein_notation": "p.Gly2301Ter",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "This variant is associated with alternative splicing that may attenuate its pathogenicity.",
        "assays": [
          "mESC-based functional assay",
          "RT-PCR",
          "Western blot analysis"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a group of nonsense variants that may produce alternative transcripts.",
      "key_quotes": [
        "Variant c.6901G>T almost exclusively produced the \u2206(E12) transcript."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 7,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}